These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

432 related articles for article (PubMed ID: 16212004)

  • 81. Review article: Non-alcoholic fatty liver disease.
    Alba LM; Lindor K
    Aliment Pharmacol Ther; 2003 Apr; 17(8):977-86. PubMed ID: 12694079
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Iron and steatohepatitis.
    Corradini E; Pietrangelo A
    J Gastroenterol Hepatol; 2012 Mar; 27 Suppl 2():42-6. PubMed ID: 22320915
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Similarities and differences in the pathogenesis of alcoholic and nonalcoholic steatohepatitis.
    Syn WK; Teaberry V; Choi SS; Diehl AM
    Semin Liver Dis; 2009 May; 29(2):200-10. PubMed ID: 19387919
    [TBL] [Abstract][Full Text] [Related]  

  • 84. [Steatohepatitis and metabolic and nutritional abnormalities].
    Deugnier Y; Lainé F
    Gastroenterol Clin Biol; 2003 May; 27(5 Suppl):B9-12. PubMed ID: 12843931
    [No Abstract]   [Full Text] [Related]  

  • 85. Liver fibrosis in alcoholic liver disease.
    Bataller R; Gao B
    Semin Liver Dis; 2015 May; 35(2):146-56. PubMed ID: 25974900
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Liver steatosis and nonalcoholic steatohepatitis: from pathogenesis to therapy.
    Hernández-Pérez E; León García PE; López-Díazguerrero NE; Rivera-Cabrera F; Del Ángel Benítez E
    Medwave; 2016 Sep; 16(8):e6535. PubMed ID: 27690306
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Nonalcoholic fatty liver disease: diagnosis and management.
    Wilkins T; Tadkod A; Hepburn I; Schade RR
    Am Fam Physician; 2013 Jul; 88(1):35-42. PubMed ID: 23939604
    [TBL] [Abstract][Full Text] [Related]  

  • 88. [Non-alcoholic steatohepatitis : pathology and pathogenesis].
    Namikawa C; Zhang H; Toi M
    Nihon Rinsho; 2006 Jun; 64(6):1107-13. PubMed ID: 16768117
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Will Studies in Nonalcoholic Steatohepatitis Help Manage Alcoholic Steatohepatitis?
    Sundaram V; Morgan TR
    Clin Liver Dis; 2019 Feb; 23(1):157-165. PubMed ID: 30454829
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Progression of alcoholic and non-alcoholic steatohepatitis: common metabolic aspects of innate immune system and oxidative stress.
    Sakaguchi S; Takahashi S; Sasaki T; Kumagai T; Nagata K
    Drug Metab Pharmacokinet; 2011; 26(1):30-46. PubMed ID: 21150132
    [TBL] [Abstract][Full Text] [Related]  

  • 91. The role of cytokines and chemokines in the development of steatohepatitis.
    Lalor PF; Faint J; Aarbodem Y; Hubscher SG; Adams DH
    Semin Liver Dis; 2007 May; 27(2):173-93. PubMed ID: 17520517
    [TBL] [Abstract][Full Text] [Related]  

  • 92. ["Alcoholic" liver damage in nonalcoholics: nonalcoholic steatohepatitis].
    Feist D
    Dtsch Med Wochenschr; 1998 Feb; 123(8):237. PubMed ID: 9526494
    [No Abstract]   [Full Text] [Related]  

  • 93. [Non-alcoholic steatohepatitis: natural history and diagnosis].
    Larrey D
    Gastroenterol Clin Biol; 2003; 27(8-9):793-8. PubMed ID: 14586250
    [No Abstract]   [Full Text] [Related]  

  • 94. [Study of clinical efficiency of essential phospholipids and silymarin combination in nonalcoholic and alcoholic steatohepatitis].
    Iakimchuk GN; Gendrikson LN
    Eksp Klin Gastroenterol; 2011; (7):64-9. PubMed ID: 22364002
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Early-phase alcoholic liver disease: an update on animal models, pathology, and pathogenesis.
    Ramaiah S; Rivera C; Arteel G
    Int J Toxicol; 2004; 23(4):217-31. PubMed ID: 15371166
    [TBL] [Abstract][Full Text] [Related]  

  • 96. [Non-invasive assessment of fatty liver].
    Egresi A; Lengyel G; Hagymási K
    Orv Hetil; 2015 Apr; 156(14):543-51. PubMed ID: 25819147
    [TBL] [Abstract][Full Text] [Related]  

  • 97. The role of hepatic fat accumulation in pathogenesis of non-alcoholic fatty liver disease (NAFLD).
    Liu Q; Bengmark S; Qu S
    Lipids Health Dis; 2010 Apr; 9():42. PubMed ID: 20426802
    [TBL] [Abstract][Full Text] [Related]  

  • 98. [Effectiveness of the new plant hepatoprotector--Ropren in patients with non-alcoholic steatohepatitis].
    Golovanova EV; Vinnitskaia EV; Shaposhnikova NA; Petrakov AV; Mel'kina ES
    Eksp Klin Gastroenterol; 2010; (7):97-102. PubMed ID: 21033090
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Cytokines in alcoholic and nonalcoholic steatohepatitis.
    Tilg H; Diehl AM
    N Engl J Med; 2000 Nov; 343(20):1467-76. PubMed ID: 11078773
    [No Abstract]   [Full Text] [Related]  

  • 100. Clinical features and natural history of nonalcoholic steatosis syndromes.
    Falck-Ytter Y; Younossi ZM; Marchesini G; McCullough AJ
    Semin Liver Dis; 2001; 21(1):17-26. PubMed ID: 11296693
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.